Some diabetes drugs like liraglutide, semaglutide, and dulaglutide may help protect the heart and lower the chance of serious heart problems in people with type 2 diabetes who already have heart...

GLP-1 receptor agonists, a group of diabetes medications, do not raise the risk of serious heart problems in adults with type 2 diabetes.

Among adults with type 2 diabetes starting injectable treatment, those using GLP-1 receptor agonists had a lower risk of heart attack, stroke, or death over two years compared to those using basal insulin, based on statistical analysis of patient data.

In adults who are overweight or obese but do not have diabetes, medications that activate GLP-1 receptors lower the likelihood of heart attacks, strokes, and other serious heart-related events compared to a placebo.

Diabetes drugs like semaglutide and liraglutide cut heart attacks, strokes, and kidney failure by up to a third — and they work fast, even before blood sugar drops, likely by calming down harmful inflammation in the body.

If you're an overweight or obese adult without diabetes, taking GLP-1 drugs like Ozempic might lower your chances of having a heart attack by about 27% compared to taking a fake pill.